The increased concentrations of CCL-21 and LIGHT after 1-year follow-up in MINOCA patients compared to the decreased concentrations of the above indicators in MI-CAD patients (Table 3) may indicate ongoing inflammation in the vessel walls during MINOCA [24,25]. The gene discussed is TNFSF14; the disease is myocardial infarction.